Notice for pemigatinib (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
pemigatinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate release tablet
Indication
Treatment of cholangiocarcinoma (CCA)
Therapeutic area
Oncology